Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy

• Han-Yue Mo ,

  Contributed equally to this work with: Han-Yue Mo, Ying-Yang Liao

  Affiliation Department of Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China

  ⨯
• Ying-Yang Liao ,

  Contributed equally to this work with: Han-Yue Mo, Ying-Yang Liao

  Affiliation Department of Nutrition, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China

  ⨯
• Xue-Mei You ,

  * E-mail: youxuemei1@126.com (XMY); zhongjianhong66@163.com; zhongjianhong@gxmu.edu.cn (JHZ)

  Affiliations Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China

  ⨯
• Alessandro Cucchetti,

  Affiliation Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna, Bologna, Italy

  ⨯
• Bao-Hong Yuan,

  Affiliation Department of General Surgery, Yan’An Hospital Affiliated to Kunming Medical University, Kunming, China

  ⨯
• Ru-Hong Li,

  Affiliation Department of General Surgery, Yan’An Hospital Affiliated to Kunming Medical University, Kunming, China

  ⨯
• Jian-Hong Zhong ,

  * E-mail: youxuemei1@126.com (XMY); zhongjianhong66@163.com; zhongjianhong@gxmu.edu.cn (JHZ)

  Affiliations Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China

  http://orcid.org/0000-0002-1494-6396

  ⨯
• Le-Qun Li

  Affiliations Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China

  ⨯